Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene study could unlock clues to esophageal cancer survival

NCT ID NCT07322627

First seen Jan 10, 2026 · Last updated May 20, 2026 · Updated 18 times

Summary

This study looks at how a specific gene, ALDH2, which helps break down alcohol, might affect how long people with esophageal cancer live. Researchers will follow 700 patients for up to 150 months to see if certain gene variations are linked to better or worse survival. The goal is to better understand why some patients do better than others, which could guide future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.